Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 15

Publication Record

Connections

Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence.
Hsi RS, Yan PL, Goldfarb DS, Egbuji A, Si Y, Shahinian V, Hollingsworth JM
(2021) Urology 149: 81-88
MeSH Terms: Adolescent, Adult, Allopurinol, Female, Follow-Up Studies, Humans, Kidney Calculi, Male, Middle Aged, Recurrence, Secondary Prevention, Thiazides, Treatment Outcome, Young Adult
Added July 2, 2021
0 Communities
1 Members
0 Resources
14 MeSH Terms
Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.
Abdullahi SU, DeBaun MR, Jordan LC, Rodeghier M, Galadanci NA
(2019) Pediatr Neurol 95: 73-78
MeSH Terms: Adolescent, Anemia, Sickle Cell, Antisickling Agents, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Hydroxyurea, Infant, Male, Nigeria, Prospective Studies, Recurrence, Secondary Prevention, Stroke
Added March 24, 2020
0 Communities
1 Members
0 Resources
16 MeSH Terms
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS, Hirtz D, Casella JF
(2014) N Engl J Med 371: 699-710
MeSH Terms: Adolescent, Anemia, Sickle Cell, Blood Transfusion, Cerebral Infarction, Child, Child, Preschool, Female, Ferritins, Hemoglobin, Sickle, Humans, Intelligence, Intention to Treat Analysis, Male, Secondary Prevention, Single-Blind Method, Transfusion Reaction
Added October 7, 2014
1 Communities
1 Members
0 Resources
16 MeSH Terms
Improving outcomes by changing hemodialysis practice patterns.
Fissell R, Hakim RM
(2013) Curr Opin Nephrol Hypertens 22: 675-80
MeSH Terms: Anemia, Anticoagulants, Hemodialysis Solutions, Humans, Hypertension, Hypertrophy, Left Ventricular, Nutritional Status, Renal Dialysis, Secondary Prevention, Time Factors, Treatment Outcome, Vascular Access Devices
Added May 20, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms
Clinical practice guideline: Tympanostomy tubes in children.
Rosenfeld RM, Schwartz SR, Pynnonen MA, Tunkel DE, Hussey HM, Fichera JS, Grimes AM, Hackell JM, Harrison MF, Haskell H, Haynes DS, Kim TW, Lafreniere DC, LeBlanc K, Mackey WL, Netterville JL, Pipan ME, Raol NP, Schellhase KG
(2013) Otolaryngol Head Neck Surg 149: S1-35
MeSH Terms: Age Factors, Anti-Bacterial Agents, Child, Child, Preschool, Equipment Design, Hearing Loss, Humans, Infant, Middle Ear Ventilation, Otitis Media, Patient Selection, Risk Assessment, Secondary Prevention, Treatment Outcome
Added March 7, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN
(2012) Biol Blood Marrow Transplant 18: 1069-75
MeSH Terms: Adolescent, Adult, Aged, CTLA-4 Antigen, Female, Graft vs Tumor Effect, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Risk Factors, Secondary Prevention, Survival Analysis, T-Lymphocytes, Cytotoxic, Tissue Donors, Transplantation, Homologous, Treatment Outcome
Added December 10, 2013
0 Communities
3 Members
0 Resources
19 MeSH Terms
What is the evidence for using hydroxyurea for secondary stroke prevention?
Lebensburger JD, DeBaun MR, Thompson AA
(2011) Hematology Am Soc Hematol Educ Program 2011: 440-2
MeSH Terms: Blood Transfusion, Child, Humans, Hydroxyurea, Male, Secondary Prevention, Stroke
Added November 27, 2013
1 Communities
1 Members
0 Resources
7 MeSH Terms
Choosing a treatment for patients at the time a fracture is presented.
Tanner SB
(2011) Curr Osteoporos Rep 9: 156-9
MeSH Terms: Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Denosumab, Diphosphonates, Fractures, Spontaneous, Humans, Osteoporosis, RANK Ligand, Secondary Prevention, Teriparatide
Added January 20, 2015
0 Communities
1 Members
0 Resources
10 MeSH Terms
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome.
Clark WB, Strickland SA, Barrett AJ, Savani BN
(2010) Haematologica 95: 860-3
MeSH Terms: Animals, Humans, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Postoperative Complications, Secondary Prevention, Stem Cell Transplantation, Transplantation, Homologous
Added March 28, 2014
0 Communities
1 Members
0 Resources
8 MeSH Terms
Preventing glycaemic relapse in recently controlled type 2 diabetes patients: a randomised controlled trial.
Huizinga MM, Gebretsadik T, Garcia Ulen C, Shintani AK, Michon SR, Shackleford LO, Wolff KL, Brown AW, Rothman RL, Elasy TA
(2010) Diabetologia 53: 832-9
MeSH Terms: Adolescent, Adult, Aged, Community Health Services, Diabetes Mellitus, Type 2, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Male, Middle Aged, Patient Education as Topic, Patient Selection, Secondary Prevention, Treatment Outcome
Added February 23, 2015
0 Communities
1 Members
0 Resources
15 MeSH Terms